| A contemporary prostate cancer grading system: a validated alternative to the Gleason score JI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, ... European urology 69 (3), 428-435, 2016 | 1695 | 2016 |
| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012 | 992 | 2012 |
| The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters B Delahunt, JC Cheville, G Martignoni, PA Humphrey, C Magi-Galluzzi, ... The American journal of surgical pathology 37 (10), 1490-1504, 2013 | 833 | 2013 |
| A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ... European urology 66 (3), 550-560, 2014 | 757 | 2014 |
| Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant A Urisman, RJ Molinaro, N Fischer, SJ Plummer, G Casey, EA Klein, ... PLoS pathogens 2 (3), e25, 2006 | 750 | 2006 |
| The Cell Cycle Inhibitor p27 Is an Independent Prognostic Marker in Small (T1a,b) Invasive Breast Carcinomas P Tan, B Cady, M Wanner, P Worland, B Cukor, C Magi-Galluzzi, P Lavin, ... Cancer research 57 (7), 1259-1263, 1997 | 517 | 1997 |
| Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies D Knezevic, AD Goddard, N Natraj, DB Cherbavaz, KM Clark-Langone, ... BMC genomics 14, 1-12, 2013 | 402 | 2013 |
| Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients AJ Gill, O Hes, T Papathomas, M Šedivcová, PH Tan, A Agaimy, ... The American journal of surgical pathology 38 (12), 1588-1602, 2014 | 350 | 2014 |
| TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african‐american and japanese patients C Magi‐Galluzzi, T Tsusuki, P Elson, K Simmerman, C LaFargue, ... The Prostate 71 (5), 489-497, 2011 | 331 | 2011 |
| Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association H Aydin, C Magi-Galluzzi, BR Lane, L Sercia, JI Lopez, BI Rini, M Zhou The American journal of surgical pathology 33 (2), 289-297, 2009 | 322 | 2009 |
| Saturation technique does not improve cancer detection as an initial prostate biopsy strategy JS Jones, A Patel, L Schoenfield, JC Rabets, CD Zippe, C Magi-Galluzzi The Journal of urology 175 (2), 485-488, 2006 | 318 | 2006 |
| RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ... The lancet oncology 15 (13), 1469-1480, 2014 | 278 | 2014 |
| Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies AW Partin, L Van Neste, EA Klein, LS Marks, JR Gee, DA Troyer, ... The Journal of urology 192 (4), 1081-1087, 2014 | 274 | 2014 |
| International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension … C Magi-Galluzzi, AJ Evans, B Delahunt, JI Epstein, DF Griffiths, ... Modern Pathology 24 (1), 26-38, 2011 | 263 | 2011 |
| Tuberous sclerosis–associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients J Guo, MS Tretiakova, ML Troxell, AO Osunkoya, O Fadare, AR Sangoi, ... The American journal of surgical pathology 38 (11), 1457-1467, 2014 | 253 | 2014 |
| Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney H Aydin, L Chen, L Cheng, S Vaziri, H He, R Ganapathi, B Delahunt, ... The American journal of surgical pathology 34 (11), 1608-1621, 2010 | 243 | 2010 |
| Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. M Loda, P Capodieci, R Mishra, H Yao, C Corless, W Grigioni, Y Wang, ... The American journal of pathology 149 (5), 1553, 1996 | 236 | 1996 |
| Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. C Magi-Galluzzi, R Mishra, M Fiorentino, R Montironi, H Yao, P Capodieci, ... Laboratory investigation; a journal of technical methods and pathology 76 (1 …, 1997 | 233 | 1997 |
| The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer JI Epstein, MB Amin, SW Fine, F Algaba, M Aron, DE Baydar, AL Beltran, ... Archives of pathology & laboratory medicine 145 (4), 461-493, 2021 | 226 | 2021 |
| Fumarate hydratase–deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome K Trpkov, O Hes, A Agaimy, M Bonert, P Martinek, C Magi-Galluzzi, ... The American journal of surgical pathology 40 (7), 865-875, 2016 | 225 | 2016 |
Eric A. KleinChairman Emeritus, Glickman Urological and Kidney Institute, Cleveland ClinicBestätigte E-Mail-Adresse bei ccf.org
